Instil Bio, Inc. (TIL)
TIL Stock Price Chart
Explore Instil Bio, Inc. interactive price chart. Choose custom timeframes to analyze TIL price movements and trends.
TIL Company Profile
Discover essential business fundamentals and corporate details for Instil Bio, Inc. (TIL) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
19 Mar 2021
Employees
14.00
Website
https://instilbio.comCEO
Bronson Crouch
Description
Instil Bio, Inc. operates as a clinical-stage biopharmaceutical firm, concentrating its efforts on devising novel therapeutic options for individuals battling cancer. A cornerstone of their research involves the advancement of autologous tumor-infiltrating lymphocyte (TIL) cell therapies. Their developmental portfolio features ITIL-168, currently under investigation for a range of malignancies including melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer. Another promising candidate, ITIL-306, is engineered to identify folate receptor alpha (FOLR1) and is being explored for gynecological cancers, non-small cell lung cancer, renal cancer, and other conditions. This company was founded in 2018 and has its principal office situated in Dallas, Texas.
TIL Financial Timeline
Browse a chronological timeline of Instil Bio, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Aug 2026
EPS estimate is -$0.35.
Earnings released on 15 May 2026
EPS came in at -$0.62 matching the estimated -$0.62.
Earnings released on 27 Mar 2026
EPS came in at -$1.21 surpassing the estimated -$2.31 by +47.62%.
Earnings released on 13 Nov 2025
EPS came in at -$2.01 falling short of the estimated -$2.00 by -0.50%.
Earnings released on 13 Aug 2025
EPS came in at -$3.24 falling short of the estimated -$1.72 by -88.37%.
Earnings released on 13 May 2025
EPS came in at -$4.32 falling short of the estimated -$2.02 by -113.86%.
Earnings released on 4 Mar 2025
EPS came in at -$1.82 surpassing the estimated -$3.75 by +51.47%.
Earnings released on 13 Nov 2024
EPS came in at -$3.54 falling short of the estimated -$2.08 by -70.19%.
Earnings released on 13 Aug 2024
EPS came in at -$2.29 surpassing the estimated -$3.04 by +24.67%.
Earnings released on 10 May 2024
EPS came in at -$3.74 falling short of the estimated -$2.16 by -73.15%.
Earnings released on 21 Mar 2024
EPS came in at -$1.99 surpassing the estimated -$2.84 by +29.93%, while revenue for the quarter reached $7.67m .
Stock split effective on 8 Dec 2023
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 Nov 2023
EPS came in at -$10.40 falling short of the estimated -$2.80 by -271.43%.
Earnings released on 14 Aug 2023
EPS came in at -$2.20 surpassing the estimated -$4.00 by +45.00%.
Earnings released on 31 Mar 2023
EPS came in at -$7.20 surpassing the estimated -$9.00 by +20.00%.
Earnings released on 27 Mar 2023
EPS came in at -$8.29 falling short of the estimated -$0.41 by -1.92k%.
Earnings released on 14 Nov 2022
EPS came in at -$7.40 surpassing the estimated -$8.80 by +15.91%.
Earnings released on 12 Aug 2022
EPS came in at -$8.00 matching the estimated -$8.00.
Earnings released on 16 May 2022
EPS came in at -$7.20 surpassing the estimated -$7.60 by +5.26%.
Earnings released on 7 Mar 2022
EPS came in at -$8.60 falling short of the estimated -$7.40 by -16.22%.
Earnings released on 15 Nov 2021
EPS came in at -$6.60 matching the estimated -$6.60.
Earnings released on 12 Aug 2021
EPS came in at -$5.40 falling short of the estimated -$4.20 by -28.57%.
TIL Stock Performance
Access detailed TIL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
